000950 重药控股
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额(2,330,265)(186,737)508,534285,829250,165
投资活动产生之现金流量净额(61,763)(182,464)(358,384)(191,239)(969,508)
筹资活动产生之现金流量净额(668,376)48,334252,4921,179,8701,542,203
汇率变动对现金及现金等价物的影响--------(120)
现金及现金等价物净增加/(减少)(3,060,404)(320,867)402,6421,274,459822,740
期初现金及现金等价物余额4,786,9835,107,8504,705,2073,430,7482,608,008
期末现金及现金等价物余额1,726,5794,786,9835,107,8504,705,2073,430,748